HIGHLIGHTS
- who: Sabrina Chiloiro from the Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Roma, Italy have published the research: Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the role of partial response and resistance to first gen-SSA in the choice of second line treatments and their outcomes. The reaching of the biochemical control of the growth hormone (GH) and insulin like growth factor-I (IGF-I) hyper-secretion and the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.